251 related articles for article (PubMed ID: 28253224)
1. Malignant Mesothelioma Mortality - United States, 1999-2015.
Mazurek JM; Syamlal G; Wood JM; Hendricks SA; Weston A
MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(8):214-218. PubMed ID: 28253224
[TBL] [Abstract][Full Text] [Related]
2. Malignant Mesothelioma Mortality in Women - United States, 1999-2020.
Mazurek JM; Blackley DJ; Weissman DN
MMWR Morb Mortal Wkly Rep; 2022 May; 71(19):645-649. PubMed ID: 35552365
[TBL] [Abstract][Full Text] [Related]
3. Malignant mesothelioma mortality--United States, 1999-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(15):393-6. PubMed ID: 19390506
[TBL] [Abstract][Full Text] [Related]
4. Global burden of mesothelioma attributable to occupational asbestos exposure in 204 countries and territories: 1990-2019.
Chen Z; Cai Y; Ou T; Zhou H; Li H; Wang Z; Cai K
J Cancer Res Clin Oncol; 2024 May; 150(5):282. PubMed ID: 38806867
[TBL] [Abstract][Full Text] [Related]
5. Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure.
Ferrante D; Chellini E; Merler E; Pavone V; Silvestri S; Miligi L; Gorini G; Bressan V; Girardi P; Ancona L; Romeo E; Luberto F; Sala O; Scarnato C; Menegozzo S; Oddone E; Tunesi S; Perticaroli P; Pettinari A; Cuccaro F; Mattioli S; Baldassarre A; Barone-Adesi F; Cena T; Legittimo P; Marinaccio A; Mirabelli D; Musti M; Pirastu R; Ranucci A; Magnani C;
Occup Environ Med; 2017 Dec; 74(12):887-898. PubMed ID: 28775133
[TBL] [Abstract][Full Text] [Related]
6. Diseases attributable to asbestos exposure: years of potential life lost, United States, 1999-2010.
Bang KM; Mazurek JM; Wood JM; Hendricks SA
Am J Ind Med; 2014 Jan; 57(1):38-48. PubMed ID: 24108494
[TBL] [Abstract][Full Text] [Related]
7. Malignant mesothelioma mortality in the United States, 1999-2001.
Bang KM; Pinheiro GA; Wood JM; Syamlal G
Int J Occup Environ Health; 2006; 12(1):9-15. PubMed ID: 16523977
[TBL] [Abstract][Full Text] [Related]
8. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
[TBL] [Abstract][Full Text] [Related]
9. Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990.
Miller A
Am J Ind Med; 2005 May; 47(5):458-62. PubMed ID: 15828068
[TBL] [Abstract][Full Text] [Related]
10. Projection of asbestos related diseases in the United States, 1985-2009. I. Cancer.
Lilienfeld DE; Mandel JS; Coin P; Schuman LM
Br J Ind Med; 1988 May; 45(5):283-91. PubMed ID: 3378008
[TBL] [Abstract][Full Text] [Related]
11. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases.
Roggli VL; Sharma A; Butnor KJ; Sporn T; Vollmer RT
Ultrastruct Pathol; 2002; 26(2):55-65. PubMed ID: 12036093
[TBL] [Abstract][Full Text] [Related]
12. A decade of malignant mesothelioma surveillance in Korea.
Jung SH; Kim HR; Koh SB; Yong SJ; Chung MJ; Lee CH; Han J; Eom MS; Oh SS
Am J Ind Med; 2012 Oct; 55(10):869-75. PubMed ID: 22544626
[TBL] [Abstract][Full Text] [Related]
13. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
Garabrant DH; Pastula ST
Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
[TBL] [Abstract][Full Text] [Related]
14. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
Mezei G; Chang ET; Mowat FS; Moolgavkar SH
Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Barbieri PG; Sommigliana AB
Med Lav; 2016 Jul; 107(4):315-26. PubMed ID: 27464904
[TBL] [Abstract][Full Text] [Related]
16. Occupational asbestos exposure, lung-fiber concentration and latency time in malignant mesothelioma.
Mowé G; Gylseth B; Hartveit F; Skaug V
Scand J Work Environ Health; 1984 Oct; 10(5):293-8. PubMed ID: 6523093
[TBL] [Abstract][Full Text] [Related]
17. Estimating the number of asbestos-related lung cancer deaths in Great Britain from 1980 to 2000.
Darnton AJ; McElvenny DM; Hodgson JT
Ann Occup Hyg; 2006 Jan; 50(1):29-38. PubMed ID: 16126764
[TBL] [Abstract][Full Text] [Related]
18. Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS).
Gilham C; Rake C; Hodgson J; Darnton A; Burdett G; Peto Wild J; Newton M; Nicholson AG; Davidson L; Shires M; Treasure T; Peto J;
Int J Epidemiol; 2018 Dec; 47(6):1745-1756. PubMed ID: 29534192
[TBL] [Abstract][Full Text] [Related]
19. Silica, asbestos, man-made mineral fibers, and cancer.
Steenland K; Stayner L
Cancer Causes Control; 1997 May; 8(3):491-503. PubMed ID: 9498906
[TBL] [Abstract][Full Text] [Related]
20. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study.
Ferrante D; Mirabelli D; Silvestri S; Azzolina D; Giovannini A; Tribaudino P; Magnani C
Am J Ind Med; 2020 Feb; 63(2):135-145. PubMed ID: 31821579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
